3D Nongadolinium-Enhanced ECG-Gated MRA of the Distal Lower Extremities: Preliminary Clinical Experience

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 1, 2008, Pages 181-189

  Lim, Ruth P ^a,d   Hecht, Elizabeth M ^a   Xu, Jian ^b   Babb, James S ^a   Oesingmann, Niels ^b   Wong, Samson ^a   Muhs, Bart E ^a,c   Gagne, Paul ^a   Lee, Vivian S ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c Yale Medical Group   (United States)

^d HW 202 ^*  (United States)

Author keywords

Magnetic resonance angiography (MRA); Non contrast; Peripheral arterial disease (PAD)

Indexed keywords

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; ARTIFACT; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; LEG ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PREDICTION; PRIORITY JOURNAL; RADIOLOGIST; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ARTIFACTS; CONSTRICTION, PATHOLOGIC; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MOTION; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 46849094498     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21416     Document Type: Article

References (31)

1. Pasternak RC, Criqui MH, Benjamin EJ, et al. Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation 2004;109:2605-2612.
2. Hughes K, Domenig CM, Hamdan AD, et al. Bypass to plantar and tarsal arteries: an acceptable approach to limb salvage. J Vasc Surg 2004;40:1149-1157.
3. Aulivola B, Pomposelli FB. Dorsalis pedis, tarsal and plantar artery bypass. J Cardiovasc Surg (Torino) 2004;45:203-212.
4. Pomposelli FB, Kansal N, Hamdan AD, et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003;37:307-315.
5. Borrello JA. MR angiography versus conventional X-ray angiography in the lower extremities: everyone wins. Radiology 1993;187:615-617.
6. Baum RA, Rutter CM, Sunshine JH, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. American College of Radiology Rapid Technology Assessment Group. JAMA 1995;274:875-880.
7. Ruehm SG, Hany TF, Pfammatter T, Schneider E, Ladd M, Debatin JF. Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR Am J Roentgenol 2000;174:1127-1135.
8. Meaney JF, Ridgway JP, Chakraverty S, et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 1999;211:59-67.
9. Steffens JC, Schafer FK, Oberscheid B, et al. Bolus-chasing contrast-enhanced 3D MRA of the lower extremity. Comparison with intraarterial DSA. Acta Radiol 2003;44:185-192.
10. Bezooijen R, van den Bosch HC, Tielbeek AV, et al. Peripheral arterial disease: sensitivity-encoded multiposition MR angiography compared with intraarterial angiography and conventional multi-position MR angiography. Radiology 2004;231:263-271.
11. Leiner T, Kessels AG, Nelemans PJ, et al. Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. Radiology 2005;235:699-708.
12. Vavrik J, Rohrmoser GM, Madani B, Ersek M, Tscholakoff D, Bucek RA. Comparison of MR angiography versus digital subtraction angiography as a basis for planning treatment of lower limb occlusive disease. J Endovasc Ther 2004;11:294-301.
13. Loewe C, Schoder M, Rand T, et al. Peripheral vascular occlusive disease: evaluation with contrast-enhanced moving-bed MR angiography versus digital subtraction angiography in 106 patients. AJR Am J Roentgenol 2002;179:1013-1021.
14. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-1108.
15. Gadolinium-containing contrast agents for magnetic resonance imaging (MRI): Omniscan, OptiMARK, Magnevist, ProHance and MultiHance. In: United States Food and Drug Administration (FDA): Public Health Advisory, 2006.
16. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243:148-157. 17. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide- associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007;188:586-592.
17. Perazella MA, Rodby RA. Gadolinium use in patients with kidney disease: a cause for concern. Semin Dial 2007;20:179-185.
18. Pedersen M. Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 2007;25:881-883.
19. Marckmann P, Skov L, Rossen K, Heaf JG, Thomsen HS. Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant 2007;22:3174-3178.
20. O'Hare AM, Bertenthal D, Shlipak MG, Sen S, Chren MM. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol 2005;16:514-519.
21. Urata J, Miyazaki M, Wada H, Nakaura T, Yamashita Y, Takahashi M. Clinical evaluation of aortic diseases using nonenhanced MRA with ECG-triggered 3D half-Fourier FSE. J Magn Reson Imaging 2001;14:113-119.
22. Wedeen VJ, Meuli RA, Edelman RR, et al. Projective imaging of pulsatile flow with magnetic resonance. Science 1985;230:946-948.
23. Miyazaki M, Sugiura S, Tateishi F, Wada H, Kassai Y, Abe H. Non-contrast-enhanced MR angiography using 3D ECG-synchronized half-Fourier fast spin echo. J Magn Reson Imaging 2000;12:776-783.
24. Miyazaki M, Takai H, Sugiura S, Wada H, Kuwahara R, Urata J. Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging. Radiology 2003;227:890-896.
25. Fink C, Ley S, Kroeker R, Requardt M, Kauczor HU, Bock M. Time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the chest: combination of parallel imaging with view sharing (TREAT). Invest Radiol 2005;40:40-48.
26. Yucel EK, Kaufman JA, Geller SC, Waltman AC. Atherosclerotic occlusive disease of the lower extremity: prospective evaluation with two-dimensional time-of-flight MR angiography. Radiology 1993;187:637-641.
27. Kaufman JA, McCarter D, Geller SC, Waltman AC. Two-dimensional time-of-flight MR angiography of the lower extremities: artifacts and pitfalls. AJR Am J Roentgenol 1998;171:129-135.
28. Steffens JC, Link J, Muller-Hulsbeck S, Freund M, Brinkmann G, Heller M. Cardiac-gated two-dimensional phase-contrast MR angiography of lower extremity occlusive disease. AJR Am J Roentgenol 1997;169:749-754.
29. Deshpande VS, Shea SM, Laub G, Simonetti OP, Finn JP, Li D. 3D magnetization-prepared true-FISP: a new technique for imaging coronary arteries. Magn Reson Med 2001;46:494-502.
30. Coenegrachts KL, Hoogeveen RM, Vaninbroukx JA, et al. High-spatial-resolution 3D balanced turbo field-echo technique for MR angiography of the renal arteries: initial experience. Radiology 2004;231:237-242.
31. Xu J, Oesingmann N, Stemmer A, et al. Reduced acquisition window with parallel technique improves non contrast 3D HASTE MRA imaging. In: Proc 14th Meeting ISMRM, Seattle, 2006; Abstract 1931.